Effect of D-amphetamine on Reward Functioning
Status: | Recruiting |
---|---|
Healthy: | No |
Age Range: | 18 - 35 |
Updated: | 7/18/2018 |
Start Date: | January 24, 2018 |
End Date: | November 1, 2018 |
Contact: | Scott D Lane, PhD |
Email: | ms.CNRAresearch@uth.tmc.edu |
Phone: | 713-486-2578 |
The purpose of this study is to establish the dose-response curve for therapeutic doses of
d-amphetamine on tasks of motivation and reward learning in the same participants and to use
d-amphetamine as a dopaminergic probe to test newer theories about the role of dopamine in
reward-related decision-making.
d-amphetamine on tasks of motivation and reward learning in the same participants and to use
d-amphetamine as a dopaminergic probe to test newer theories about the role of dopamine in
reward-related decision-making.
Inclusion Criteria:
- Healthy individuals
Exclusion Criteria:
- Individuals with a body mass index (BMI) <19 or >26, as this alters dosing
requirements
- Individuals with high blood pressure, abnormal Electrocardiography (EKG), any medical
condition requiring regular medication (except birth control), any other regular use
of a drug or supplement with potentially hazardous interactions with d-amphetamine
(e.g. St. John's wort), or any other medical contraindication to amphetamine
administration as determined by our study physician
- Individuals who report no prior experience with recreational drugs of any kind
(including alcohol), or who report a previous adverse reaction to amphetamine
- Individuals with a current Diagnostic and Statistical Manual of Mental Disorders-V
(DSM-V) Axis I diagnosis, excluding mild Substance Use Disorders (≤ 3 symptoms)
- Individuals with a lifetime history of moderate to severe Substance Use Disorder (≥ 4
symptoms), mania or psychosis.
- Women who are pregnant.
- individuals smoking more than 10 cigarettes per week will also be excluded, to avoid
confounding the effects of nicotine withdrawal with the effects of the study
drugs/procedures, as participants will not be allowed to smoke during the sessions.
- individuals with less than a high-school level of education or fluency in English will
be excluded as our questionnaires require high-school level fluency in English, and
have not been translated and validated in other languages.
We found this trial at
1
site
7000 Fannin St
Houston, Texas 77030
Houston, Texas 77030
(713) 500-4472
Phone: 713-486-2578
University of Texas Health Science Center at Houston The University of Texas Health Science Center...
Click here to add this to my saved trials